About: Long-acting gonadotropin hormone-releasing hormone analog used to treat uteri

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Long-acting gonadotropin hormone-releasing hormone analog used to treat uteri Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 May 1986

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в травні 1986 (uk) artículu científicu espublizáu en mayu de 1986 (ast) im Mai 1986 veröffentlichter wissenschaftlicher Artikel (de) scientific article published on 01 May 1986 (en)
publication date	wds:Q70284016-F4E2F3CF-0914-40EA-9B3F-8AE7272EE420
publication date	1986-05-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q70284016-B3038DDD-A94E-44C2-B413-1BC252BEEA95
language of work or name	English
cites work	wds:Q70284016-04BE5593-C547-4606-B0CA-388F361A76AA wds:Q70284016-0B75C99C-1C71-43DE-8E83-C6A6B4BD7106 wds:Q70284016-1C0DCD4A-38AE-4A72-B2C1-13A13F3C33E4 wds:Q70284016-4088D4F8-0AEE-4403-B39E-1030F4802C66 wds:Q70284016-4695E1A4-D17A-4C42-9116-612353661383 wds:Q70284016-48E30537-51AE-4713-BD20-0129C7F992B7 wds:Q70284016-5B713ED9-D683-4078-B83F-615401F4A1D8 wds:Q70284016-72032216-6B1A-43D0-9AB0-121E877C596B wds:Q70284016-72E7A68C-694D-44A0-A55A-1F88E426940D wds:Q70284016-9DECA788-0A0C-498E-B7A1-0CA2ED86CA73 wds:Q70284016-B25FA943-63E8-4F0E-8A92-8585F5AAD81F wds:Q70284016-D6262F5A-EADB-4253-89F0-DDC3AFDEC9FF wds:Q70284016-E633DD96-5101-47CD-9EF9-93CCB54A18AB wds:Q70284016-EB82931A-6B27-4504-9932-74E40F46E951 wds:Q70284016-F7FC7DFE-38DE-4833-B2B0-278F662C494E
cites work	The inaccuracy of total uterine volume measurements: sources of error and a proposed solution. Uterine leiomyomata: etiology, symptomatology, and management. Short-term treatment of idiopathic precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone. A preliminary report Therapeutic use of pituitary desensitization with a long-acting lhrh agonist: a potential new treatment for idiopathic precocious puberty The measurement of estrone sulfate in plasma A conservative approach to the management of uterine leiomyoma: pituitary desensitization by a luteinizing hormone-releasing hormone analogue Radioimmunoassay for luteinizing hormone in human plasma or serum: physiological studies SARCOMA ARISING IN A LEIOMYOMA OF THE UTERUS: FACTORS INFLUENCING PROGNOSIS Shrinkage of a uterine fibroid after subcutaneous infusion of a LHRH agonist Regression of leiomyomata uteri following hypoestrogenism induced by repetitive luteinizing hormone-releasing hormone agonist treatment: preliminary report Effects of the (imBzl)D-His6, Des-Gly analog of GnRH on gonadotropin and estradiol secretion in normal women Submucosal leiomyomas and infertility Clinical applications of LHRH and its analogues Reversible hypogonadism induced by a luteinizing hormone-releasing hormone (LH-RH) agonist (Buserelin) as a new therapeutic approach for endometriosis Pregnancy success following abdominal myomectomy for infertility
author name string	wds:Q70284016-0B7C82E5-FBDA-4AC7-BFC6-58857337F5AE wds:Q70284016-69D76A2C-F1C0-4988-A572-2AD39EBB079F wds:Q70284016-B4EB67D0-DCB3-4BE8-934E-2A29931E0737 wds:Q70284016-BB2E2326-26EB-4D3E-AAC0-D5B03F23B122 wds:Q70284016-C927774D-5AEE-4B33-ABF9-5BFB7AF30DD4 wds:Q70284016-EAF0E2DE-FEBD-4824-BB41-14A67FD94FAB
author name string	R Anderson R L Collins C A Winkel D L Loriaux C C Coddington T H Shawker
rdfs:label	Long-acting gonadotropin hormone-releasing hormone analog used to treat uteri (en) Long-acting gonadotropin hormone-releasing hormone analog used to treat uteri (nl)
skos:prefLabel	Long-acting gonadotropin hormone-releasing hormone analog used to treat uteri (en) Long-acting gonadotropin hormone-releasing hormone analog used to treat uteri (nl)
name	Long-acting gonadotropin hormone-releasing hormone analog used to treat uteri (en) Long-acting gonadotropin hormone-releasing hormone analog used to treat uteri (nl)
title	wds:Q70284016-EAA44E85-227B-41D4-B1E6-DA692DF2A490
title	Long-acting gonadotropin hormone-releasing hormone analog used to treat uteri (en)
page(s)	wds:Q70284016-52FAB262-4890-4D76-98E5-42935BF1B787
page(s)	624-629
instance of	wds:Q70284016-E3C18D64-C855-4DD6-AA5F-9DB58036EDBF
instance of	scholarly article
PubMed ID	wds:Q70284016-32613095-7C56-428C-BF2A-578015C82C33
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/3084300
PubMed ID	3084300
published in	wds:Q70284016-574963D1-4977-4D25-8E42-209A1CE2AE76
published in	Fertility and Sterility
issue	wds:Q70284016-E67A5077-86A3-49A3-B117-91B889E778A7
volume	wds:Q70284016-9447A2E9-95BD-49DC-8495-E1EFF0A73C60
issue	5
volume	45
DOI	wds:Q70284016-7FB157B6-8ED4-4980-96FF-6EBBE170A942
DOI	http://dx.doi.org/10.1016/S0015-0282(16)49332-5
DOI	10.1016/S0015-0282(16)49332-5
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q70284016
is cites work of	A randomized, double-blind trial of a gonadotropin releasing-hormone agonist (leuprolide) with or without medroxyprogesterone acetate in the treatment of leiomyomata uteri Therapeutic hysteroscopic procedures Endometrial ablation for the treatment of menorrhagia: A comparison of patients with normal, enlarged, and fibroid uteri Five decades of progress in management of the infertile couple. Preoperative reduction of uterine fibroids in only 16 days by administration of a gonadotrophin-releasing hormone antagonist (Cetrotide) Efficacy of a low-dose leuprolide acetate depot in the treatment of uterine leiomyomata in Japanese women Predictors of uterine volume reduction in women with myomas treated with a gonadotropin-releasing hormone agonist Uterine leiomyosarcoma diagnosed during treatment with agonist of luteinizing hormone-releasing hormone for presumed uterine fibroid A randomized, placebo-controlled, double-blind study evaluating the efficacy of leuprolide acetate depot in the treatment of uterine leiomyomata A randomized, placebo-controlled, double-blind study evaluating leuprolide acetate depot treatment before myomectomy Goserelin therapy before surgery for uterine fibroids Quantitative MRI of uterine leiomyomas during triptorelin treatment: reproducibility of volume assessment and predictability of treatment response. Fibroids and menorrhagia Efficacy of a gonadotropin-releasing hormone agonist in the treatment of uterine leiomyomata: long-term follow-up Treatment of leiomyomata uteri with D-Trp6-luteinizing hormone-releasing hormone Treatment of leiomyomata with intranasal or subcutaneous leuprolide, a gonadotropin-releasing hormone agonist Shrinkage of uterine fibroids during therapy with goserelin (Zoladex): a luteinizing hormone-releasing hormone agonist administered as a monthly subcutaneous depot GnRH agonists and antagonists. Current clinical status Gene therapy targeting leiomyoma: adenovirus-mediated delivery of dominant-negative estrogen receptor gene shrinks uterine tumors in Eker rat model LHRH analogues in the management of uterine fibroids, premenstrual syndrome and breast malignancies Evaluation of leuprolide acetate treatment on histopathology of uterine myomata Long-term treatment of leiomyomas with gestrinone A randomized, placebo-controlled study on the effect of cyclic intermittent etidronate therapy on the bone mineral density changes associated with six months of gonadotropin-releasing hormone agonist treatment.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software